Literature DB >> 12519395

Evidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infection.

G C Harcourt1, M Lucas, A J Godkin, M Kantzanou, R E Phillips, P Klenerman.   

Abstract

CD4+ T lymphocyte responses are thought to play a major role in control of the hepatitis C virus (HCV). Few, however, have been mapped down to the level of peptide and HLA restriction. Furthermore, the ability of such T cells to respond to viruses which differ in genotype has not been addressed in detail. In most cases of persistent infection with HCV, CD4 proliferative responses are weak or absent. From a large cohort of persistently infected patients, we identified an individual with unusually robust and persistent responses in the face of chronic infection. We firstly mapped two peptide epitopes to regions of the nonstructural protein NS4 (aa1686-1705 and aa 1746-1765). However, in contrast to the genotype 1a derived antigens used for mapping, the infecting virus was identified as genotype 3a. Strikingly, the patient's CD4 response to these epitopes were specific only for the genotype 1a sequence, and did not recognize genotype 3a synthetic peptides. Serologic assays indicated that prior exposure to HCV of genotype 1 had occurred. This patient therefore maintains strong CD4 proliferative responses which are genotype specific and not cross-reactive. The apparent 'misdirection' of these nonprotective responses has important implications for the role of natural and vaccine induced CD4 responses in the face of variable viruses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12519395      PMCID: PMC1808595          DOI: 10.1046/j.1365-2249.2003.02033.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

1.  Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients.

Authors:  A Godkin; N Jeanguet; M Thursz; P Openshaw; H Thomas
Journal:  Eur J Immunol       Date:  2001-05       Impact factor: 5.532

2.  Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.

Authors:  G Missale; R Bertoni; V Lamonaca; A Valli; M Massari; C Mori; M G Rumi; M Houghton; F Fiaccadori; C Ferrari
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 3.  Cellular immune responses against hepatitis C virus: the evidence base 2002.

Authors:  S Ward; G Lauer; R Isba; B Walker; P Klenerman
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

4.  Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.

Authors:  Amalia Penna; Gabriele Missale; Vincenzo Lamonaca; Massimo Pilli; Cristina Mori; Paola Zanelli; Albertina Cavalli; Gianfranco Elia; Carlo Ferrari
Journal:  Hepatology       Date:  2002-05       Impact factor: 17.425

5.  Two successive hepatitis C virus infections in an intravenous drug user.

Authors:  B Proust; F Dubois; Y Bacq; S Le Pogam; S Rogez; R Levillain; A Goudeau
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

6.  Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection.

Authors:  G Harcourt; S Hellier; M Bunce; J Satsangi; J Collier; R Chapman; R Phillips; P Klenerman
Journal:  J Viral Hepat       Date:  2001-05       Impact factor: 3.728

7.  Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities.

Authors:  Georg M Lauer; Kei Ouchi; Raymond T Chung; Tam N Nguyen; Cheryl L Day; Deborah R Purkis; Markus Reiser; Arthur Y Kim; Michaela Lucas; Paul Klenerman; Bruce D Walker
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

8.  The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

Authors:  P Farci; A Shimoda; A Coiana; G Diaz; G Peddis; J C Melpolder; A Strazzera; D Y Chien; S J Munoz; A Balestrieri; R H Purcell; H J Alter
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

9.  Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain.

Authors:  T Laskus; L F Wang; M Radkowski; H Vargas; M Nowicki; J Wilkinson; J Rakela
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

10.  Impairment of CD4(+) T cell responses during chronic virus infection prevents neutralizing antibody responses against virus escape mutants.

Authors:  A Ciurea; L Hunziker; P Klenerman; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

View more
  6 in total

1.  Strain-specific T-cell suppression and protective immunity in patients with chronic hepatitis C virus infection.

Authors:  Kazushi Sugimoto; David E Kaplan; Fusao Ikeda; Jin Ding; Jonathan Schwartz; Frederick A Nunes; Harvey J Alter; Kyong-Mi Chang
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

2.  Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non-genotype 1 infection.

Authors:  Julian Schulze Zur Wiesch; Georg M Lauer; Joerg Timm; Thomas Kuntzen; Martin Neukamm; Andrew Berical; Andrea M Jones; Brian E Nolan; Steve A Longworth; Victoria Kasprowicz; Cory McMahon; Alysse Wurcel; Ansgar W Lohse; Lia L Lewis-Ximenez; Raymond T Chung; Arthur Y Kim; Todd M Allen; Bruce D Walker
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

Review 3.  CD4+ T cell responses in hepatitis C virus infection.

Authors:  Nasser Semmo; Paul Klenerman
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

4.  Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice.

Authors:  Danushka K Wijesundara; Jason Gummow; Eric J Gowans; Branka Grubor-Bauk; Yanrui Li; Wenbo Yu; Benjamin J Quah; Charani Ranasinghe; Joseph Torresi
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

5.  Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection.

Authors:  Vicki M Fleming; Gillian Harcourt; Eleanor Barnes; Paul Klenerman
Journal:  J Gen Virol       Date:  2010-01-27       Impact factor: 3.891

6.  The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design.

Authors:  Annette von Delft; Isla S Humphreys; Anthony Brown; Katja Pfafferott; Michaela Lucas; Paul Klenerman; Georg M Lauer; Andrea L Cox; Silvana Gaudieri; Eleanor Barnes
Journal:  Gut       Date:  2015-06-19       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.